Bifeprunox in the Treatment of Schizophrenia
This study has been completed.
Information provided by:
First received: September 11, 2005
Last updated: January 18, 2007
Last verified: January 2007
Study of the long-term efficacy and safety of bifeprunox in the treatment of schizophrenia.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
|Official Title:||A Randomized, Double-Blind, Olanzapine-Referenced, Parallel-Group Safety and Efficacy Study of Flexible Doses of Bifeprunox in the Long-Term Treatment of Schizpohrenia (Extension of S1543003)|
Resource links provided by NLM:
Further study details as provided by Solvay Pharmaceuticals:
Contacts and Locations